Related references
Note: Only part of the references are listed.Relation of smoking status to a panel of inflammatory markers: The Framingham offspring
Yamini S. Levitzky et al.
ATHEROSCLEROSIS (2008)
Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction
Jing Tan et al.
CLINICAL CARDIOLOGY (2008)
Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18
David A. Morrow et al.
EUROPEAN HEART JOURNAL (2008)
Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention
Nihat Ozer et al.
HEART AND VESSELS (2008)
Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation
Manabu Horii et al.
HEART AND VESSELS (2008)
Association between circulating level of CD40 ligand and angiographic morphologic features indicating high-burden thrombus formation in patients with acute myocardial infarction undergoing primary coronary intervention
Ali A. Youssef et al.
CIRCULATION JOURNAL (2007)
CD40/CD40L system and vascular disease
F. Santilli et al.
INTERNAL AND EMERGENCY MEDICINE (2007)
Smoking, haemostatic factors, and cardiovascular risk
Aurelio Leone
CURRENT PHARMACEUTICAL DESIGN (2007)
The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease
Wen-Lieng Lee et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis -: Results from the Dallas Heart Study
JA de Lemos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction - The smoker's paradox revisited
G Weisz et al.
AMERICAN HEART JOURNAL (2005)
Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers
SA Harding et al.
CIRCULATION (2004)
Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization
MI Furman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Soluble CD40L -: Risk prediction after acute coronary syndromes
N Varo et al.
CIRCULATION (2003)
Soluble CD40 ligand in acute coronary syndromes
C Heeschen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation
L Nannizzi-Alaimo et al.
CIRCULATION (2003)
CD40L stabilizes arterial thrombi by a beta(3) integrin-dependent mechanism
P Andre et al.
NATURE MEDICINE (2002)
Changes in platelet glycoprotein receptors after smoking - a flow cytometric study
S Nair et al.
PLATELETS (2001)
Share Paper
